Is this your brand? Sign in to claim ownership.

Sign in to claim this brand

MEDTRONIC VASCULAR, INC.

US

Last updated September 17, 2026

What MEDTRONIC VASCULAR, INC. makes

The company manufactures non-bioabsorbable soft-tissue mesh anchors, including systems and cassettes for endoscopic or minimally invasive fixation, such as the Heli-FX EndoAnchor System and its thoracic variants. It also produces an introducer sheath with a hydrophilic coating for procedural use.

These devices are regulated under FDA Class II and Class III classifications, with authorisation records in 510(k), PMA, and UDI registries. The company is based in the United States.

Written from this company's registered devices by an AI model, and not verified by a human reviewer.

Frequently asked questions

What types of medical devices does Medtronic Vascular, Inc. primarily manufacture?

Medtronic Vascular, Inc. specializes in non-bioabsorbable soft-tissue mesh anchors designed for endoscopic or minimally invasive surgical fixation. Their portfolio includes systems like the Heli-FX EndoAnchor System and its thoracic-specific variants, as well as ancillary components such as cassettes. Additionally, they produce procedural tools like the Sentrant Introducer Sheath with a hydrophilic coating, which reduces friction during insertion.

Where is Medtronic Vascular, Inc. based, and how does that affect its regulatory oversight?

Medtronic Vascular, Inc. is headquartered in the United States, which means its devices fall under the jurisdiction of the U.S. Food and Drug Administration (FDA). The FDA classifies these devices as either Class II or Class III, depending on their risk level and intended use, requiring pre-market authorisation through pathways like 510(k) clearances, Premarket Approvals (PMAs), or Unique Device Identification (UDI) registrations.

Which regulatory registries list Medtronic Vascular, Inc.’s devices, and why?

Medtronic Vascular, Inc.’s devices are listed in the FDA’s 510(k), PMA, and UDI registries. The 510(k) pathway applies to Class II devices deemed substantially equivalent to existing approved products, while Class III devices—often higher-risk—require a Premarket Approval (PMA) to demonstrate safety and effectiveness. The UDI registry ensures traceability and transparency in the supply chain, tracking devices throughout their lifecycle for compliance and recall purposes.

How are Medtronic Vascular, Inc.’s devices classified by the FDA, and what does that mean for their use?

The FDA classifies Medtronic Vascular, Inc.’s devices as either Class II or Class III. Class II devices, like some mesh anchors, typically require performance standards and 510(k) clearance to prove they’re as safe and effective as comparable legacy products. Class III devices, such as certain high-risk fixation systems, require a Premarket Approval (PMA) to demonstrate safety and efficacy through rigorous clinical trials, as they lack a predicate device or pose greater risks.

AI-generated from registry data and not verified by a human reviewer.

Information

Country
US
Address
3576 Unocal Pl, Santa Rosa, CA, 95403
Website
medtronic.com
LinkedIn
—
Facebook
—
Phone
+1(800)633-8766
PRRC Contact
—
EUDAMED SRN
—
FDA FEI Number
3001452571
DUNS Number
080009661

Catalogue (509)

Page 3 of 11
DeviceModel / ReferenceRegistriesClassStatus
Percupass Tunneling Tool Model 3452 K772013
FDA 510(k)
Class IActive
Minix/Minix St Pulse Generators K932884
FDA 510(k)
Class IIIActive
Pulse Generator, A-V Seq. K772202
FDA 510(k)
Class IIIActive
Medtronic Models 4011 & 4511 K822781
FDA 510(k)
Class IIIActive
Modified #3587 Resume Se-4/#3487 Pisces-Quad K873675
FDA 510(k)
Class IIActive
Pisces #3487 Epidural Lead For Spinal K831746
FDA 510(k)
Class IIActive
Model 1812 Control Console, Accessoriex K780952
FDA 510(k)
Class IIActive
Mvr Collapsible Venous Reservoir Bag K920774
FDA 510(k)
Class IIActive
Medtronic Models 5966/5967, Etc. K800069
FDA 510(k)
Class IIIActive
Model 6495 Bipolar Temporary Myocardial Pacing Lead K012460
FDA 510(k)
Class IIActive
Tuna System, Models 8909, 8929, 8930, 8934 K052413
FDA 510(k)
Class IIActive
Maxima Plus Hollow Fiber Oxygenator K941473
FDA 510(k)
Class IIActive
Medtronic Models 6907/6901 K790766
FDA 510(k)
Class IIIActive
Medtronic Model 546 K782108
FDA 510(k)
Class IIActive
Cardioblate Dispersive Electrode Adapter (accessory), Model 60884 K043291
FDA 510(k)
Class IIActive
Radiolucent Ecg Electrode Model No: 1680 K890201
FDA 510(k)
Class IIActive
Medtronic Model 9410 Teletrace Receiver K791778
FDA 510(k)
Class IIActive
Medtronic Classix Models 8436/8437/8438 K871866
FDA 510(k)
Class IIIActive
Alternate Package Config. For Implant. Pulse Gen. K862974
FDA 510(k)
Class IIIActive
Model 5866-46 Sleeve Kit K910568
FDA 510(k)
Class IIActive
Endocardial Pacing Leads-Anchoring Sleeve Modified K884005
FDA 510(k)
Class IIIActive
Epidural Lead - Model 3481 K780001
FDA 510(k)
Class IIActive
7f Sherpa Nx Guide Catheter K051846
FDA 510(k)
Class IIActive
Bipolar Endocardial Pacing Lead, M. 6902 K780622
FDA 510(k)
Class IIIActive
Attain 6216a-Mp Multi-Purpose Guide Catheter For Left-Heart Delivery K024032
FDA 510(k)
Class IIActive
Unipolar Spectrax Impl. Pulse Generat. K811350
FDA 510(k)
Class IIIActive
Medtronic Temptron K790261
FDA 510(k)
Class IIIActive
Modified Memorytrace Er Model 4221 Ecg Monitor K915769
FDA 510(k)
Class IIActive
InTRAkit K162097
FDA 510(k)
Class IIActive
Models 5069/5071 Myocardial Pacing Leads K902002
FDA 510(k)
Class IIIActive
Models 4012/4512 Transvenous Tined- K842032
FDA 510(k)
Class IIIActive
Model 5985 Pacemaker Pulse Generator K800285
FDA 510(k)
Class IIIActive
Modification Of Maxima Forte' Hollow Fiber Oxygenator With Balance Biocompatible Surface With Plasma Resistent Fiber (m0 K984271
FDA 510(k)
Class IIActive
Model 5013 Transvenous Ventricular Pacing Lead K874792
FDA 510(k)
Class IIIActive
Modified Label For/Spectrax Sxt Implant. Pulse Gen K862071
FDA 510(k)
Class IIIActive
Model 6492 Unipolar Temporary Atrial Pacing Lead K012458
FDA 510(k)
Class IIActive
Unipolar Pediatric Temporary Pacing Lead, #6491 K902342
FDA 510(k)
Class IIActive
Xtrel, Model Number 3425 K883780
FDA 510(k)
Class IIActive
Model 2188 Coronary Sinus Lead. K961936
FDA 510(k)
Class IIIActive
Medtronic Twist Lock Anchor (partnumber 103953/3550tla) K972906
FDA 510(k)
Class IIActive
Promeon Hydrogel Dressing #45 Sterile W/ Mesh K915359
FDA 510(k)
Class IActive
Model 3487a Pisces Epidural Lead K881491
FDA 510(k)
Class IIActive
Medtronic Model 3991a, 3992a, 3993a, 3994a Leads Or Transverse Tripolar Leads Or Ttl K964172
FDA 510(k)
Class IIActive
Pacing System Analyzer K803313
FDA 510(k)
Class IIActive
Neuromuscular Stimulator 3105 K840467
FDA 510(k)
Class IIActive
Everest 20 Inflation Device and 3-way Stopcock (AC2200);Everest 30 Inflation Device and 3-way Stopcock (AC3200);Everest 20 Survival Kit containing:1. Everest 20 Device with 3-way Stopcock, 2. Piton Y-Adaptor , 3. Metal Guidewire Insertion Needle, 4. Torque Handle (AC2205P); Everest 30 Survival Kit containing:1. Everest 30 Device with 3-way Stopcock, 2. Piton Y-Adaptor, 3. Metal Guidewire Insertion Needle, 4. Torque Handle (AC3205P) K220773
FDA 510(k)
Class IIActive
Transxchange Support Catheter K033540
FDA 510(k)
Class IIActive
Pacing Lead Model 6991a K772104
FDA 510(k)
Class IIIActive
Medtronic Model 3990 Pns Lead K925952
FDA 510(k)
Class IIActive
Medtronic Angiographic Guide Wires K082873
FDA 510(k)
Class IIActive

Related Companies

Authorised Representatives

No authorised representatives on record.

Importers

Not available yet.

Notified Bodies

Not available yet.

Authorities

Not available yet.

FDA Recalls (100)

Recalls reported by this firm to the FDA. Listed at company level — FDA recall records don't identify a specific catalogue device.

Medtronic Vascular, Inc. has 234 recall records spanning from June 8, 2004, to March 23, 2022, with statuses recorded as open, classified, or terminated. The reasons cited include mechanical failures such as detachment of spindle components, radiopaque marker bonds, or taper tips during stent graft deployment; labeling errors such as incorrect usable lengths, master labels, and stentstop assemblies; sterility concerns due to compromised package integrity; and manufacturing defects like retained manufacturing materials in embolization systems. Some records reference procedural complications, such as difficulty flushing delivery systems or potential endoleaks and stent fractures.

AI-generated summary of the recall records listed below. It describes what the records state and is not an assessment of this manufacturer.

DateRecall No.ClassStatusReason
Mar 23, 2022Z-1043-2022—open, classified

Packaging for Balloon Catheters may be damaged resulting in loss of sterility.

Mar 23, 2022Z-1042-2022—open, classified

Packaging for Balloon Catheters may be damaged resulting in loss of sterility.

Dec 21, 2021Z-0657-2022—open, classified

Stent Graft Systems built with specific batches of taper tip assemblies have the potential for the taper tip to detach from the delivery system. Detachment of the taper tip during the implant procedure may lead to a secondary intervention to attempt to remove the taper tip, either by endovascular retrieval or surgical conversion. There is also potential that the taper tip is intentionally left behind in the patient, at the physician's discretion, if not easily removable.

Oct 15, 2021Z-0291-2022—open, classified

Due to, during stent graft deployment, the spindle may detach from the distal end of the spindle hypotube.

Oct 15, 2021Z-0292-2022—open, classified

Due to, during stent graft deployment, the spindle may detach from the distal end of the spindle hypotube.

Oct 15, 2021Z-0290-2022—open, classified

During stent graft deployment, the spindle may detach from the distal end of the spindle hypotube

Jun 7, 2021Z-2135-2021—open, classified

During stent graft deployment, the radiopaque (RO) marker bond detached from the distal end of the graft cover.

Jun 7, 2021Z-2136-2021—open, classified

During product complaint investigation, it was determined that during stent graft deployment, the radiopaque (RO) marker bond detached from the distal end of the graft cover.

May 4, 2021Z-1860-2021—terminated

The component part numbers intended for shipment to a third-party, where they are further processed into kits and sterilized were instead shipped directly to customers.

Apr 28, 2021Z-1976-2021—terminated

Incorrect stentstop assembly (18fr) was used to build the delivery system component of the device. Correct stentstop assembly is 20fr.

Feb 12, 2021Z-1201-2021—open, classified

Due to the presence of type IIIb endoleaks, stent fractures, and stent ring enlargement.

Jan 15, 2021Z-1248-2021—terminated

Sterility may be compromised due to an unsealed pouch

Jan 15, 2021Z-1245-2021—terminated

Sterility may be compromised due to an unsealed pouch

Jan 15, 2021Z-1246-2021—terminated

Sterility may be compromised due to an unsealed pouch

Jan 15, 2021Z-1247-2021—terminated

Sterility may be compromised due to an unsealed pouch

Aug 25, 2020Z-0088-2021—terminated

Subsequent failure of catheters in the field and failed quality testing

Aug 25, 2020Z-0087-2021—terminated

Subsequent failure of catheters in the field and failed quality testing

Aug 25, 2020Z-0089-2021—terminated

Subsequent failure of catheters in the field and failed quality testing

Mar 15, 2019Z-2605-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2644-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2651-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2749-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2698-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2699-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2732-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2643-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2579-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2574-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2709-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2589-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2575-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2674-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2591-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2604-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2603-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2738-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2562-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2750-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2686-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2688-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2621-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2684-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2721-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2744-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2682-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2733-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2656-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2662-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2647-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2630-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2565-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2654-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2649-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2571-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2635-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2576-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2626-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2692-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2611-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2714-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2633-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2578-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2600-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2618-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2583-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2636-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2752-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2596-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2581-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2726-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2632-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2672-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2593-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2568-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2685-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2652-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2671-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2639-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2585-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2680-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2638-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2710-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2719-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2646-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2718-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2564-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2742-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2594-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2664-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2715-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2717-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2736-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2658-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2650-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2592-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2569-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2597-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2634-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2712-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2747-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.